Business Information
The group's principal activity is to develop, manufacture and market immunoassay diagnostic test kits. The group owns two technologies for screening drugs of abuse, a workplace screening test and a preliminary test for use by laboratories. The group's drugs of abuse screening products offer health care, law enforcement, government, industrial safety and educational professionals, self-contained, one-step screening devices capable of identifying illicit drug use. The products of the group include rapid drug screen(R), rapid one(R), rapid tec(R), oralstat(R), drug detector(tm), rapid drug screen scan-r(tm) and rapid tec cup(tm). As of Feb 2004, the group had 18 distributors representing 30 countries outside the United States.
|
|
Name |
Title
|
Email
|
| Edmund Jaskiewicz | Chmn., Pres. | N/A | | Melissa Waterhouse | Corp. Sec. - Corporate Compliance | N/A | | Henry Wells | VP - Product Development | N/A | | Martin Gould | Chief Scientific Officer, Exec. VP | N/A | | Stefan Parker | CFO, Exec. VP | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 13,838 | 196 | | 2005 | 13,015 | (376) | | 2004 | 12,241 | 266
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
